Nasus Pharma NSRX
NYSE NSRX
$2.91 -0.02 (-0.87%)
As of: Nov 10, 2026 · 1:28 PM EST

Nasus Pharma (NSRX) Non-Current Assets (2024 - 2026)

Updated

Nasus Pharma's Non-Current Assets came in at $138,000 for Q2 2026, down 60.3% from $348,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Non-Current Assets was $149,000, down 42.7% from FY2024.

  • Going back by year, Non-Current Assets was $260,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 141.07 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 110.20 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 87.87 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 34.86 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 159.99 Bn
10 Nasus Pharma 23.71 Mn 23.71 Mn - 149,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138,000.00
Dec 31, 2025 149,000.00
Jun 30, 2025 348,000.00
Dec 31, 2024 260,000.00
API Access

Nasus Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=NSRX&period=max&api_key=YOUR_API_KEY